-
1
المؤلفون: Takeshi Kadokura, Satoshi Yoshida, Kenichi Kazuta, Atsunori Kaibara, Masako Saito, Junko Toyoshima, Eiji Ueyama
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, endocrine system diseases, Endocrinology, Diabetes and Metabolism, Urology, Renal function, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Pharmacokinetics, Diabetes mellitus, Type 2 diabetes mellitus, Internal Medicine, Medicine, Original Research, Disease progression, business.industry, Type 2 Diabetes Mellitus, nutritional and metabolic diseases, SGLT2 inhibitor, medicine.disease, Exposure–response, Ipragliflozin, chemistry, Pharmacodynamics, Sodium/Glucose Cotransporter 2, Suglat, SGLT2 Inhibitor, business, Antidiabetic effect
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9a6b681bbfb65f4dcab95fbf9453f1fTest
http://europepmc.org/articles/PMC7136367Test -
2
المؤلفون: Atsunori Kashiwagi, Wim Wilpshaar, Marina Vladimirovna Shestakova, John P.H. Wilding, Yuichiro Ito, Satoshi Yoshida, Masahiro Noguchi
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, Diabetic ketoacidosis, Endocrinology, Diabetes and Metabolism, 030209 endocrinology & metabolism, 030204 cardiovascular system & hematology, Placebo, Pooled analysis, Sodium-glucose cotransporter 2 inhibitor, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Diabetes mellitus, Internal medicine, Type 2 diabetes mellitus, Internal Medicine, Medicine, Adverse effect, Original Research, business.industry, Incidence (epidemiology), medicine.disease, 3. Good health, Discontinuation, Clinical trial, Ipragliflozin, chemistry, Safety, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4bf8082ea8110f944b305543fc36545Test
http://europepmc.org/articles/PMC6848447Test -
3
المؤلفون: Tetsuo Seki, Kazunori Utsunomiya, Atsutaka Yasui, Jisoo Lee, Gang Cheng, Yasuo Terauchi, Kosuke Shiki
المصدر: Diabetes Therapy
مصطلحات موضوعية: medicine.medical_specialty, GLP-1 receptor agonist, Endocrinology, Diabetes and Metabolism, Urology, Empagliflozin, 030209 endocrinology & metabolism, Type 2 diabetes, 030204 cardiovascular system & hematology, 03 medical and health sciences, Sodium-glucose cotransporter 2 inhibitors, 0302 clinical medicine, Diabetes mellitus, Internal Medicine, medicine, Glucagon-like peptide 1 receptor, Original Research, Add-on therapy, business.industry, Liraglutide, Type 2 Diabetes Mellitus, medicine.disease, Blood pressure, Tolerability, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24f75c0b9e6b76ce24873545cf654757Test
http://europepmc.org/articles/PMC6531579Test -
4
المؤلفون: Dinesh Nagrale, Vikram Singh, Sanjay Kalra
المصدر: Advances in Therapy
مصطلحات موضوعية: medicine.medical_specialty, medicine.medical_treatment, Kidney Glomerulus, Renal function, 030209 endocrinology & metabolism, Review, 030204 cardiovascular system & hematology, urologic and male genital diseases, 03 medical and health sciences, 0302 clinical medicine, Diabetes mellitus, Endocrinology, Internal medicine, Chronic kidney disease, Medicine, Humans, Hypoglycemic Agents, Pharmacology (medical), Diabetic Nephropathies, Nephroprotection, Sodium-Glucose Transporter 2 Inhibitors, Medicine(all), business.industry, Insulin, Renal Reabsorption, General Medicine, medicine.disease, Renal glucose reabsorption, Renal Elimination, Glucose, Glomerular hyperfiltration, Nephrology, Sodium/Glucose Cotransporter 2, Glomerulus, Renal threshold, business, SGLT2 inhibitors, Kidney disease
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be318bf6757a915b6be61acea05b7d01Test
http://europepmc.org/articles/PMC5020120Test